166 related articles for article (PubMed ID: 24283268)
1. Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.
Piguet AC; Majumder S; Maheshwari U; Manjunathan R; Saran U; Chatterjee S; Dufour JF
Clin Sci (Lond); 2014 Jun; 126(11):775-84. PubMed ID: 24283268
[TBL] [Abstract][Full Text] [Related]
2. Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis.
Majumder S; Piguet AC; Dufour JF; Chatterjee S
Eur J Pharmacol; 2013 Apr; 705(1-3):86-95. PubMed ID: 23454556
[TBL] [Abstract][Full Text] [Related]
3. Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.
Semela D; Piguet AC; Kolev M; Schmitter K; Hlushchuk R; Djonov V; Stoupis C; Dufour JF
J Hepatol; 2007 May; 46(5):840-8. PubMed ID: 17321636
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
5. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
7. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells.
Qu H; Yang X
Cell Biochem Biophys; 2015 Mar; 71(2):931-6. PubMed ID: 25326336
[TBL] [Abstract][Full Text] [Related]
10. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
[TBL] [Abstract][Full Text] [Related]
11. [Simvastatin inhibits activation of hepatic stellate cells and promotes activation of adenosine monophosphate-activated protein kinase].
Cao W; Yan L; Wang W; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):304-9. PubMed ID: 22964154
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin.
Cui W; Wang M; Maegawa H; Teranishi Y; Kawada N
Biochem Biophys Res Commun; 2012 Aug; 425(3):642-8. PubMed ID: 22850540
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro.
Masola V; Carraro A; Zaza G; Bellin G; Montin U; Violi P; Lupo A; Tedeschi U
BMC Gastroenterol; 2015 Sep; 15():118. PubMed ID: 26369804
[TBL] [Abstract][Full Text] [Related]
15. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
[TBL] [Abstract][Full Text] [Related]
17. [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS].
Wang W; Zhao CY; Wang YD; He X; Shen C; Cao W; Zhou JY; Zhen Z
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):917-22. PubMed ID: 22525505
[TBL] [Abstract][Full Text] [Related]
18. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
20. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Huynh H; Ong R; Soo KC
Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
